Trince
Gent, BE · 2 known investors
Trince is a Ghent University spin-off developing photoporation technology for physical transfection of cells as an alternative to viral vectors and electroporation. Its technology, including the Lumipore platform, targets R&D, manufacturing, and GMP-compliant clinical applications such as cell and gene therapy.
Founders & leadership
P
Philip
K
Kevin
Investors · 2
Frequently asked questions
- What does Trince do?
- Trince is a Ghent University spin-off developing photoporation technology for physical transfection of cells as an alternative to viral vectors and electroporation. Its technology, including the Lumipore platform, targets R&D, manufacturing, and GMP-compliant clinical applications such as cell and gene therapy.
- Who are Trince's investors?
- Trince's investors include Novalis Biotech, Qbic Fund.
- Where is Trince headquartered?
- Trince is headquartered in Gent, BE.